Market closedNon-fractional
Align Technology/ALGN
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Align Technology
Align Technology is the leading manufacturer of clear aligners. Invisalign, its main product, was approved by the Food and Drug Administration in 1998 and has since dominated, controlling over 90% of the market. Invisalign can treat roughly 90% of all malocclusion cases (misaligned teeth), and there are over 230,000 Invisalign-trained dentists and orthodontists. In 2022, Invisalign treated over 2 million cases, or roughly 10% of all orthodontic cases for the year, and it has treated over 14 million patients since its launch. Align also sells intraoral scanners under the brand iTero, which captures digital impressions of patients' teeth and illustrates treatment plans. Over 85% of Invisalign cases are submitted by digital scans, and iTero scans make up over half of these scans.
Ticker
ALGN
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
Tempe, United States
Employees
21,670
Website
www.aligntech.com
Align Technology Metrics
BasicAdvanced
$17B
Market cap
38.34
P/E ratio
$5.90
EPS
1.66
Beta
-
Dividend rate
Price and volume
Market cap
$17B
Beta
1.66
Financial strength
Current ratio
1.182
Quick ratio
0.883
Long term debt to equity
2.616
Total debt to equity
2.616
Management effectiveness
Return on assets (TTM)
6.94%
Return on equity (TTM)
12.09%
Valuation
Price to earnings (TTM)
38.34
Price to revenue (TTM)
4.337
Price to book
4.54
Price to tangible book (TTM)
5.35
Price to free cash flow (TTM)
49.588
Growth
Revenue change (TTM)
5.50%
Earnings per share change (TTM)
45.11%
3-year revenue growth (CAGR)
4.31%
3-year earnings per share growth (CAGR)
-12.41%
What the Analysts think about Align Technology
Analyst Ratings
Majority rating from 16 analysts.
Align Technology Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$997M
4.25%
Net income
$105M
-15.32%
Profit margin
10.52%
-18.83%
Align Technology Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$2.22
$2.14
$2.42
$2.14
-
Expected
$2.03
$2.26
$2.18
$1.97
$2.31
Surprise
9.36%
-5.44%
11.16%
8.83%
-
Align Technology News
AllArticlesVideos
Align Technology, Inc. (ALGN) Q2 2024 Earnings Call Transcript
Seeking Alpha·2 days ago
Invisalign's maker says consumers downshifted to lower-priced clear braces
Market Watch·2 days ago
Operation Smile Announces Align Technology as Title Sponsor of International Student Leadership Conference
PRNewsWire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Align Technology stock?
Align Technology (ALGN) has a market cap of $17B as of July 27, 2024.
What is the P/E ratio for Align Technology stock?
The price to earnings (P/E) ratio for Align Technology (ALGN) stock is 38.34 as of July 27, 2024.
Does Align Technology stock pay dividends?
No, Align Technology (ALGN) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Align Technology dividend payment date?
Align Technology (ALGN) stock does not pay dividends to its shareholders.
What is the beta indicator for Align Technology?
Align Technology (ALGN) has a beta rating of 1.66. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Align Technology stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.